Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study

AIDS

Volumn 14, Issue 17, 2000, Pages 2671-2678

  McDermott, David H ^a   Beecroft, Matthew J ^a   Kleeberger, Cynthia A ^c   Al Sharif, Fadwa M ^d   Ollier, William E R ^d   Zimmerman, Peter A ^e   Boatin, Boakye A ^f   Leitman, Susan F ^b   Detels, Roger ^g   Hajeer, Ali H ^d   Murphy, Philip M ^a,h  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Chemokines; Epidemiology; Pathogenesis; Risk factors; Virus cell interaction

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR5; RANTES;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; VIRUS CELL INTERACTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; ALLELES; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; DISEASE PROGRESSION; ETHNIC GROUPS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; NORTH AMERICA; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS (GENETICS); RANTES; SURVIVAL RATE;

EID: 0034491524     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200012010-00006     Document Type: Article

References (46)

1. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
2. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells
3. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
4. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1
5. Identification of a major coreceptor for primary isolates of HIV-1
6. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
7. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
8. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
9. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: A novel inhibitory mechanism of HIV infectivity
10. CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: Role of signal transduction
11. RANTES stimulates cell-mediated transmission of HIV-1 infection
12. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
13. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: Association with low expression of CCR5 and high production of beta-chemokines
14. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS)
15. Genetic acceleration of AIDS progression by a promoter variant of CCR5
16. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants
17. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
18. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
19. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study
20. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
21. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk
22. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study
23. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation
24. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression
25. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC)
26. The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection
27. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure
28. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele
29. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro
30. HIV-1 infectability of CD4+ lymphocytes with relation to beta-chemokines and the CCR5 coreceptor
31. Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection
32. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
33. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES
34. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: The Multicenter AIDS Cohort Study
35. The Multicenter AIDS Cohort Study: Rationale, organization, and selected characteristics of the participants
36. Resistance to HIV-1 infection. Multicenter AIDS Cohort Study
37. Human immunodeficiency virus type I infection in homosexual men who remain seronegative for prolonged periods
38. Organization of the chemokine gene cluster on human chromosome 17q11.2 containing the genes for CC chemokine MPIF-1, HCC-2, HCC-1, LEC, and RANTES
39. Genomic organization and transcriptional regulation of the RANTES chemokine gene
40. A polymorphism at position -403 in the human RANTES promoter
41. A rare polymorphism at position -28 in the human RANTES promoter
42. HIV-1 infection in an individual homozygous for the CCR5 deletion allele
43. HIV-1 infection in a man homozygous for CCR5 delta 32
44. A receptor for the malarial parasite Plasmodium vivax: The erythrocyte chemokine receptor
45. The resistance factor to Plasmodium vivax in blacks. The Duffy blood-group genotype, FyFy
46. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals